Loading company details...
Latest Form 4 (Nov 4, 2026): Venrock Healthcare Capital Partners III, L.P. (10% Owner): Purchase of 8,305 shares, $223.8K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Nov 4, 2026 | Venrock Healthcare Capital Partners III, L.P. | Purchase | 8,305 | $223.8K |
| Oct 30, 2026 | Venrock Healthcare Capital Partners III, L.P. | Purchase | 10,570 | $266.7K |
| Oct 28, 2026 | Versant Ventures VII GP, L.P. | Conversion | 5,631,425 | n/a |
| Oct 27, 2026 | Venrock Healthcare Capital Partners III, L.P. | Purchase | 24,560 | $630.7K |
| Oct 26, 2026 | Laurent Fischer | Grant/Award | 13,307 | n/a |
| Oct 26, 2026 | Jane Henderson | Grant/Award | 57,666 | n/a |
| Oct 26, 2026 | William Jl Rieflin | Grant/Award | 24,840 | n/a |
| Oct 26, 2026 | Sofia Touami, Chief Business Officer | Grant/Award | 68,755 | n/a |
| Oct 26, 2026 | Steven Staben, Chief Scientific Officer | Grant/Award | 110,896 | n/a |
| Oct 26, 2026 | Chin Hyok Lee, Chief Medical Officer | Grant/Award | 73,191 | n/a |